Alfred Buck
Zurich, ZH 8005, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Gray matter gamma-hydroxy-butyric acid and glutamate reflect beta-amyloid burden at old age.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: December 05, 2023
Attenuation Correction Using Template PET Registration for Brain PET: A Proof-of-Concept Study.
Journal: Journal of imaging
Published: October 07, 2022
Low Subicular Volume as an Indicator of Dementia-Risk Susceptibility in Old Age.
Journal: Frontiers in aging neuroscience
Published: November 08, 2021
Regional brain mGlu5 receptor occupancy following single oral doses of mavoglurant as measured by [11C]-ABP688 PET imaging in healthy volunteers.
Journal: NeuroImage
Published: September 07, 2020
Brain areas with normatively greater cerebral perfusion in early life may be more susceptible to beta amyloid deposition in late life.
Journal: Cerebral circulation - cognition and behavior
Published: January 01, 2020
The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer's diseases- A simulation study combining multi-center data and ADNI-data.
Journal: PloS one
Published: August 12, 2019
Reduced uptake of [11C]-ABP688, a PET tracer for metabolic glutamate receptor 5 in hippocampus and amygdala in Alzheimer's dementia.
Journal: Brain and behavior
Published: June 07, 2019
Radiation dosimetry of [18F]-PSS232-a PET radioligand for imaging mGlu5 receptors in humans.
Journal: EJNMMI research
Published: November 13, 2018
Value of 18F-FET PET in Patients With Suspected Tumefactive Demyelinating Disease-Preliminary Experience From a Retrospective Analysis.
Journal: Clinical nuclear medicine
Published: August 29, 2018
Last Updated: 09/26/2026